CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-05 | MAZELSKY JONATHAN JAY President and CEO | Option exercise | +384 | 73,095.35 | ||
| 2023-08-05 | MAZELSKY JONATHAN JAY President and CEO | Shares withheld for taxes | −170 | $504.08 | $86K | 72,925.35 |
| 2023-08-05 | MAZELSKY JONATHAN JAY President and CEO | Option exercise · Restricted Stock Unit | −384 | 10,443 | ||
| 2023-08-03 | Lane Michael Executive Vice President | Option exercise | +1,512 | $141.60 | $214K | 5,545.99 |
| 2023-08-03 | Lane Michael Executive Vice President | Option exercise | +7,435 | $178.26 | $1.3M | 12,980.99 |
| 2023-08-03 | Lane Michael Executive Vice President | Option exercise | +7,080 | $206.94 | $1.5M | 20,060.99 |
| 2023-08-03 | Lane Michael Executive Vice President | Sale | −16,027 | $510.00 | $8.2M | 4,033.99 |
| 2023-08-03 | Lane Michael Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −1,512 | 0 | ||
| 2023-08-03 | Lane Michael Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −7,435 | 0 | ||
| 2023-08-03 | Lane Michael Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −7,080 | 1,286 | ||
| 2023-07-28 | JUNIUS DANIEL M Director | Grant or award | +14 | $552.78 | $8K | 3,009 |
| 2023-05-19 | AYERS JONATHAN W Director | Option exercise | +10,000 | $79.54 | $795K | 147,039 |
| 2023-05-19 | AYERS JONATHAN W Director | Sale | −1,138 | $486.92 | $554K | 145,901 |
| 2023-05-19 | AYERS JONATHAN W Director | Sale | −2,254 | $487.82 | $1.1M | 143,647 |
| 2023-05-19 | AYERS JONATHAN W Director | Sale | −1,308 | $488.77 | $639K | 142,339 |
| 2023-05-19 | AYERS JONATHAN W Director | Sale | −300 | $490.03 | $147K | 142,039 |
| 2023-05-19 | AYERS JONATHAN W Director | Sale | −400 | $491.59 | $197K | 141,639 |
| 2023-05-19 | AYERS JONATHAN W Director | Sale | −1,426 | $492.82 | $703K | 140,213 |
| 2023-05-19 | AYERS JONATHAN W Director | Sale | −1,229 | $494.28 | $607K | 138,984 |
| 2023-05-19 | AYERS JONATHAN W Director | Sale | −886 | $495.94 | $439K | 138,098 |
Page 41 of 52 · 1,036 trades